This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fitzpatrick, L A Articles by Miller, V Search for Related Content PubMed PubMed Citation Articles by Fitzpatrick, L A Articles by Miller, V Social Bookmarking                         What's this?

Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of arteriosclerosis

Department of Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA.

M Ruan

J Anderson

T Moraghan

Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN, USA

V Miller

Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA

Premenopausal women have a significant reduction in coronary artery disease compared to age matched males. Little is known about the mechanism underlying this cardio protective effect of estrogen. Contradictory evidence has been published and our lack of basic understanding of hormone interactions and bioavailability of different estrogens prevents definitive interpretation of these data. We demonstrate gender-specific effects in the proliferation of coronary artery vascular smooth muscle cells obtained from a sexually mature animal model. Vascular smooth muscle cells are an integral component of the atherosclerotic plaque, and inhibition of cell proliferation by estrogen may be one mechanism by which estrogen exerts its cardio protective effect. Various types of estrogen may also have different mechanistic actions on the vascular system. No differences are demonstrated in overall estradiol binding in vascular smooth muscle cells obtained from male or female animals; however, differences in c-jun, c-fos and TIEG gene expression were gender related. Inhibition of vascular smooth muscle cell proliferation may have important implications in the prevention of atherosclerotic disease and these studies may provide evidence for the cardio protective effect of estrogen.

Key Words: estrogen • athersclerosis • vascular biology

Lupus, Vol. 8, No. 5, 397-401 (1999)
DOI: 10.1177/096120339900800514


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M D Lockshin, S Gabriel, Z Zakeri, and R A Lockshin Gender, biology and human disease: report of a conference Lupus, June 1, 1999; 8(5): 335 - 338. [PDF]